ELZA at ESCRS 2025 – What to Expect
From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…
Mark Hillen
August 14, 2025
From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…
Dr. Kaweh Mansouri discusses glaucoma, AI, and modern eye care on Thomas Meyer’s podcast. ELZA Eye Institute Zurich.
Featured in the November/December 2024 issue of Glaucoma Today, an article by ELZA Consultant Surgeon Dr. Kaweh Mansouri highlights the Eyemate continuous intraocular pressure (IOP) monitoring implant.
Here’s an overview of what ELZA’s surgeons and researchers are presenting in Barcelona this year. ELZA at ESCRS 2024.
The ELZA Institute is proud to announce that Prof. Kaweh Mansouri has been included in The Ophthalmologist’s “Power List” for the third time.
The “Schweizerischen Ärztezeitung” (the Swiss Medical Journal) recently reported on ELZA’s consultant glaucoma surgeon, Prof. Dr. med. Kaweh Mansouri’s appointment as the Executive Vice President of the World Glaucoma Association (WGA) in an article titled “He fights against glaucoma”. This appointment marks the first time a Swiss and European specialist has been elected to this position within the WGA.
Let’s delve into the insightful presentations given by two of ELZA’s finest surgeons during ELZA at Swiss Ophthalmological Society (SSO)’s Swiss Eye Week 2024, highlighting the contributions of ELZA’s Medical Director, Prof. Farhad Hafezi and consultant glaucoma surgeon, Prof. Kaweh Mansouri on Wednesday, January 17th, 2024. The conference was held to educate Switzerland’s up and coming ophthalmology residents, and is a highly anticipated meeting each year. This year, the meeting was held at that Belvédère Strandhotel, Spiez.
The most recent issue of the journal, International Glaucoma Review, examined the contributions and impact of all glacucoma physicians worldwide, and ELZA’s consultant surgeon, Prof.
The ELZA team of surgeons and researchers were all in attendance, and today saw Prof. Hafezi give the attending delegates a lecture on “How to treat thin corneas”, where he examined the history of performing corneal cross-linking (CXL) for the treatment of corneal ectasias like keratoconus. He then brought delegates up-to-date on the research that has been performed over the years to improve how thin corneas are cross-linked. Finally, Prof. Hafezi demonstrated the results of the latest thin cornea cross-linking protocol, sub400, developed by ELAZA, which simplifies the process, and can let surgeons, for the first time, cross-link corneas that are as thin as 200 µm.
